L3VLUP
ProSign in

ITGR · VRTX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

ITGRVRTX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • ITGR
  • VRTX
010203040202120222023202420252026
Holders and value by quarter
QuarterITGRVRTX
Q3 20202 holders, $3.3m31 holders, $21.9bn
Q4 20201 holders, $2.3m30 holders, $18.4bn
Q1 20211 holders, $2.5m31 holders, $15.4bn
Q2 20212 holders, $5.7m30 holders, $12.7bn
Q3 20212 holders, $5.2m35 holders, $10.1bn
Q4 20212 holders, $5.4m28 holders, $12.4bn
Q1 20221 holders, $2.3m23 holders, $16.1bn
Q2 20221 holders, $2.0m25 holders, $18.1bn
Q3 20222 holders, $5.0m22 holders, $18.4bn
Q4 20222 holders, $4.6m28 holders, $18.4bn
Q1 20232 holders, $5.4m26 holders, $21.4bn
Q2 20233 holders, $19m27 holders, $24.7bn
Q3 20232 holders, $13m33 holders, $24.3bn
Q4 20233 holders, $28m32 holders, $28.6bn
Q1 20244 holders, $69m31 holders, $29.8bn
Q2 20243 holders, $163m29 holders, $33.4bn
Q3 20243 holders, $305m27 holders, $33.5bn
Q4 20244 holders, $365m26 holders, $28.5bn
Q1 20256 holders, $356m21 holders, $35.4bn
Q2 20257 holders, $376m21 holders, $32.3bn
Q3 20254 holders, $300m22 holders, $25.9bn
Q4 20258 holders, $189m26 holders, $31.8bn
Q1 20264 holders, $262m25 holders, $31.8bn
Q2 20263 holders, $247m26 holders, $34.6bn
ITGR

Integer HLDGS Corp

Holders
6
Reported value
$356m
Buyers
3
Sellers
3

Breadth 0 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
VRTX

Vertex Pharmaceuticals Inc

Holders
21
Reported value
$35.4bn
Buyers
10
Sellers
11

Breadth -1 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2025

Among the 25 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only ITGR (4)

GAMCO Investors Inc, Point72 Asset Management LP, Soros Fund Management LLC, Viking Global Investors LP

Only VRTX (19)

AllianceBernstein LP, AQR Capital Management LLC, ARK Investment Management LLC, Baillie Gifford & Co, Capital World Investors, Element Capital Management LLC, Fidelity (FMR LLC), Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, PDT Partners LLC, Renaissance Technologies LLC, T. Rowe Price Associates Inc, Wellington Management Group LLP, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →